Edesa Biotech wins CHLA Award for Best BD Deal of 2017 and Dr. Par Nijhawan Inducted into the CHLA Hall of Fame

Markham, Ontario – (WIRE)—Edesa Biotech Inc., a clinical-stage private company announced today it received the Best Business Development Deal of 2017 awarded by the Canadian Healthcare Licensing Association (CHLA). The award was accepted by Dr. Michael Brooks who stated that “It was gratifying to see the teams hard work pay off. Our team worked closely with Pharmascience Inc. in creating …

Venture Capital Helps Fund New Canadian Drug

Canada’s Edesa Biotech Inc. is one step closer to making a drug to treat diseases in dermatology and gastroenterology a reality, with funding that includes an investment from Spain, secured with the help of the Canadian Trade Commissioner Service (TCS). Bringing a new drug to market is a long, complex and expensive process. Edesa Biotech Inc., an emerging specialty pharmaceutical company in Markham, Ont., has …

Edesa Biotech Completes Financing to Develop Novel Dermatology and Anorectal Treatments

MARKHAM, ON, Sept. 20, 2017 /CNW/ – Edesa Biotech Inc., a clinical-stage private company announced today the completion of a $7 million Series A financing. The internationally syndicated investment was led by Lumira Capital and included participation from Pharmascience Inc., Inveready Technology Investment Group and a number of Canadian family offices. The funds from this financing will be used to …